The CLOVES syndrome market is growing due to emerging targeted therapies, including PI3K inhibitors, clinical trial developments, and efforts to address vascular and overgrowth anomalies in rare pediatric conditions. https://www.datamintelligence.com/research-report/cloves-syndrome-market